ATE550423T1 - Dreidimensionale kultivierte gewebe und deren verwendung - Google Patents

Dreidimensionale kultivierte gewebe und deren verwendung

Info

Publication number
ATE550423T1
ATE550423T1 AT10011579T AT10011579T ATE550423T1 AT E550423 T1 ATE550423 T1 AT E550423T1 AT 10011579 T AT10011579 T AT 10011579T AT 10011579 T AT10011579 T AT 10011579T AT E550423 T1 ATE550423 T1 AT E550423T1
Authority
AT
Austria
Prior art keywords
tissues
dimensional
organs
dimensional cultivated
cultivated tissues
Prior art date
Application number
AT10011579T
Other languages
English (en)
Inventor
Gail K Naughton
Original Assignee
Theregen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theregen Inc filed Critical Theregen Inc
Application granted granted Critical
Publication of ATE550423T1 publication Critical patent/ATE550423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00—Microcarriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
AT10011579T 2004-08-30 2005-08-30 Dreidimensionale kultivierte gewebe und deren verwendung ATE550423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60607204P 2004-08-30 2004-08-30
US69173105P 2005-06-17 2005-06-17

Publications (1)

Publication Number Publication Date
ATE550423T1 true ATE550423T1 (de) 2012-04-15

Family

ID=35447429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT10011579T ATE550423T1 (de) 2004-08-30 2005-08-30 Dreidimensionale kultivierte gewebe und deren verwendung

Country Status (7)

Country Link
US (6) US20070237750A1 (de)
EP (4) EP1789537A2 (de)
JP (2) JP2008511672A (de)
AT (1) ATE550423T1 (de)
AU (3) AU2005279934A1 (de)
CA (1) CA2578951A1 (de)
WO (2) WO2006026652A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US20070072294A1 (en) * 2004-09-30 2007-03-29 Doronin Sergey V Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
ATE500855T1 (de) * 2004-11-22 2011-03-15 Theregen Inc Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
AU2006259935B2 (en) * 2005-06-23 2011-06-23 Gambro Lundia Ab Implantable access device and method for preparing thereof
US20090209031A1 (en) * 2006-01-26 2009-08-20 Tyco Healthcare Group Lp Medical device package
GB0613031D0 (en) * 2006-06-30 2006-08-09 Renovo Ltd Medicaments
US9044385B2 (en) * 2007-05-16 2015-06-02 Abbott Cardiovascular Systems Inc. Therapeutic compositions for targeted vessel delivery
US10398804B2 (en) 2007-05-21 2019-09-03 Wake Forest University Health Sciences Progenitor cells from urine and methods for using the same
US20100111914A1 (en) 2007-05-21 2010-05-06 Yuanyuan Zhang Stem cells from urine and methods for using the same
US20100129328A1 (en) * 2007-07-24 2010-05-27 Sing George L Methods for promoting hair growth
US8535913B2 (en) 2008-01-30 2013-09-17 Histogen, Inc. Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
US8530415B2 (en) 2008-01-30 2013-09-10 Histogen, Inc. Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
US8524494B2 (en) 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
CA2714387C (en) * 2008-01-30 2018-06-19 Histogen, Inc. Extracellular matrix compositions
SI2344198T1 (sl) * 2008-09-27 2021-01-29 Jina Pharmaceuticals Inc. Farmacevtski pripravki na lipidni osnovi za topično uporabo
WO2010038232A1 (en) * 2008-10-05 2010-04-08 Hymie Friedlander Extract from conditioned medium cultured by regenerative cells
BRPI0921249A8 (pt) 2008-11-14 2018-12-04 Histogen Inc uso de matriz extracelular na preparação de uma composição,uso de matriz extracelular e agente quimioterápico na preparação de uma composição, e composições para o tratamento do cãncer
AU2010206374B2 (en) 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
WO2010124365A1 (en) 2009-04-27 2010-11-04 Ottawa Hospital Research Institute Compositions and methods for modulating stem cells and uses thereof
PT2451964T (pt) * 2009-07-10 2018-05-07 Histogen Inc Meio condiconado e composições de matriz extracelular de células cultivadas sob condições hipóxicas
FR2948286B1 (fr) 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
EP2470287A4 (de) 2009-08-28 2015-01-21 Univ Columbia Systeme, verfahren und vorrichtungen zur herstellung gasgefüllter mikroblasen
US8617892B2 (en) 2009-09-01 2013-12-31 The Trustees Of Columbia University In The City Of New York Microbubble devices, methods and systems
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도
WO2011059112A1 (ja) * 2009-11-13 2011-05-19 株式会社日立ハイテクノロジーズ 粒子含有細胞集合体
CA2812707C (en) 2010-09-27 2020-02-18 Nsgene A/S Implantable cell device with supportive and radial diffusive scaffolding
KR101061464B1 (ko) * 2010-12-30 2011-09-01 김영실 지방줄기세포의 배양액을 이용한 모발증식제재 및 이의 제조방법
CN103501796A (zh) 2011-03-04 2014-01-08 艾哈迈德·H·阿勒卡塔尼 护肤霜
CN109730959A (zh) * 2011-03-28 2019-05-10 约翰·S·阿诺尼 基于干细胞的化妆配制品及制备其的方法和系统
WO2012135176A2 (en) * 2011-03-28 2012-10-04 The Board Of Trustees Of The Leland Stanford Junior University The use of wnt agents to prevent hypoxic injury
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
KR20140062139A (ko) 2011-09-16 2014-05-22 페이트 세러퓨틱스, 인코포레이티드 Ｗnt 조성물 및 당해 조성물의 치료학적 용도
ES2690305T3 (es) 2011-09-16 2018-11-20 Ottawa Hospital Research Institute Composiciones de Wnt7a y métodos de utilización de las mismas
EP2583642A1 (de) * 2011-10-21 2013-04-24 Universitätsspital Basel Implantierbarer Stomaring
US9603897B2 (en) 2012-03-12 2017-03-28 Massachusetts Institute Of Technology Methods for treating tissue damage associated with ischemia with apolipoprotein D
RU2733838C2 (ru) * 2012-09-04 2020-10-07 Антродженезис Корпорейшн Способы получения тканей
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
JP2015112262A (ja) * 2013-12-11 2015-06-22 学校法人藤田学園 組織修復及び／又は再生促進材
US10533191B2 (en) 2014-01-15 2020-01-14 Serucell Corporation Therapeutic serum obtained from co-cultured cells
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
CZ2016644A3 (cs) * 2016-10-14 2018-06-06 Ústav experimentální medicíny AV ČR, v. v. i. Prostředek obsahující kmenové buňky k léčení posttraumatických zánětlivých reakcí a způsob jeho výroby
EP4233989A3 (de) 2017-06-07 2023-10-11 Shifamed Holdings, LLC Intravaskuläre fluidbewegungsvorrichtungen, systeme und verwendungsverfahren
EP3710076B1 (de) 2017-11-13 2023-12-27 Shifamed Holdings, LLC Intravaskuläre fluidbewegungsvorrichtungen, systeme und verwendungsverfahren
CA3083354A1 (en) * 2017-11-29 2019-06-06 Figene, Llc Interaction of fibroblasts and immune cells for activation and uses thereof
JP7410034B2 (ja) 2018-02-01 2024-01-09 シファメド・ホールディングス・エルエルシー 血管内血液ポンプならびに使用および製造の方法
US20220236255A1 (en) * 2019-06-28 2022-07-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Self-Contained Responsive Biological Systems and Methods
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US579664A (en) * 1897-03-30 Robert e
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4721096A (en) * 1986-04-18 1988-01-26 Marrow-Tech Incorporated Process for replicating bone marrow in vitro and using the same
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US4874368A (en) * 1988-07-25 1989-10-17 Micromedics, Inc. Fibrin glue delivery system
JPH0762078B2 (ja) * 1989-03-03 1995-07-05 松下電器産業株式会社 有機薄膜の形成方法
JP2678945B2 (ja) * 1989-04-17 1997-11-19 有限会社ナイセム 人工血管とその製造方法及び人工血管用基質
US5376118A (en) * 1989-05-10 1994-12-27 United States Surgical Corporation Support material for cell impregnation
US5091173A (en) * 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
AU8647991A (en) * 1991-08-26 1993-03-16 State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The Keratinocyte-derived conditioned medium as a source of growth factors
US5368563A (en) * 1991-12-18 1994-11-29 Micromedics, Inc. Sprayer assembly for physiologic glue
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US5478739A (en) * 1992-10-23 1995-12-26 Advanced Tissue Sciences, Inc. Three-dimensional stromal cell and tissue culture system
US5483658A (en) * 1993-02-26 1996-01-09 Grube; Gary W. Detection of unauthorized use of software applications in processing devices
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5605541A (en) * 1994-12-07 1997-02-25 E. R. Squibb And Sons, Inc. Fibrin sealant applicatoor
US5655081A (en) * 1995-03-08 1997-08-05 Bmc Software, Inc. System for monitoring and managing computer resources and applications across a distributed computing environment using an intelligent autonomous agent architecture
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
US5742762A (en) * 1995-05-19 1998-04-21 Telogy Networks, Inc. Network management gateway
US5612682A (en) * 1995-05-30 1997-03-18 Motorola, Inc. Method and apparatus for controlling utilization of a process added to a portable communication device
US6284284B1 (en) * 1995-06-06 2001-09-04 Advanced Tissue Sciences, Inc. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5843766A (en) * 1995-06-07 1998-12-01 Advanced Tissue Sciences, Inc. Apparatus for the growth and packaging of three dimensional tissue cultures
US6088515A (en) * 1995-11-13 2000-07-11 Citrix Systems Inc Method and apparatus for making a hypermedium interactive
US5708709A (en) * 1995-12-08 1998-01-13 Sun Microsystems, Inc. System and method for managing try-and-buy usage of application programs
US5888551A (en) * 1995-12-11 1999-03-30 University Of Miami Hair growth stimulating composition
US20010011253A1 (en) * 1998-08-04 2001-08-02 Christopher D. Coley Automated system for management of licensed software
US6006333A (en) * 1996-03-13 1999-12-21 Sun Microsystems, Inc. Password helper using a client-side master password which automatically presents the appropriate server-side password to a particular remote server
US5968116A (en) * 1996-03-27 1999-10-19 Intel Corporation Method and apparatus for facilitating the management of networked devices
US6366930B1 (en) * 1996-04-12 2002-04-02 Computer Associates Think, Inc. Intelligent data inventory & asset management systems method and apparatus
US5763267A (en) * 1996-04-16 1998-06-09 Advanced Tissue Sciences Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures
GB9608696D0 (en) * 1996-04-26 1996-07-03 Europ Computer Ind Res Electronic copy protection mechanism
US5923850A (en) * 1996-06-28 1999-07-13 Sun Microsystems, Inc. Historical asset information data storage schema
US5996010A (en) * 1996-08-29 1999-11-30 Nortel Networks Corporation Method of performing a network management transaction using a web-capable agent
US5759171A (en) * 1996-09-27 1998-06-02 Thermogenesis Corp. Sprayer for fibrin glue
US6009274A (en) * 1996-12-13 1999-12-28 3Com Corporation Method and apparatus for automatically updating software components on end systems over a network
US5908469A (en) * 1997-02-14 1999-06-01 International Business Machines Corporation Generic user authentication for network computers
US5925127A (en) * 1997-04-09 1999-07-20 Microsoft Corporation Method and system for monitoring the use of rented software
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6021438A (en) * 1997-06-18 2000-02-01 Wyatt River Software, Inc. License management system using daemons and aliasing
US6044465A (en) * 1997-07-07 2000-03-28 International Business Machines Corporation User profile storage on and retrieval from a non-native server domain for use in a client running a native operating system
US6573238B2 (en) * 1997-11-07 2003-06-03 Chiron Corporation Method for producing sustained-release formulations
US5999179A (en) * 1997-11-17 1999-12-07 Fujitsu Limited Platform independent computer network management client
US6144739A (en) * 1998-01-20 2000-11-07 Motorola, Inc. Computer network protection using cryptographic sealing software agents and objects
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
US6303136B1 (en) * 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US6243468B1 (en) * 1998-04-29 2001-06-05 Microsoft Corporation Software anti-piracy system that adapts to hardware upgrades
US6044471A (en) * 1998-06-04 2000-03-28 Z4 Technologies, Inc. Method and apparatus for securing software to reduce unauthorized use
US6324569B1 (en) * 1998-09-23 2001-11-27 John W. L. Ogilvie Self-removing email verified or designated as such by a message distributor for the convenience of a recipient
US6289378B1 (en) * 1998-10-20 2001-09-11 Triactive Technologies, L.L.C. Web browser remote computer management system
US6662805B2 (en) * 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
US6631521B1 (en) * 1999-03-29 2003-10-07 International Business Machines Corporation System, method, and program for performing program specific operations during the uninstallation of a computer program from a computer system
US20030007954A1 (en) * 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6381631B1 (en) * 1999-06-03 2002-04-30 Marimba, Inc. Method and apparatus for controlling client computer systems
US6282711B1 (en) * 1999-08-10 2001-08-28 Hewlett-Packard Company Method for more efficiently installing software components from a remote server source
US6578199B1 (en) * 1999-11-12 2003-06-10 Fujitsu Limited Automatic tracking system and method for distributable software
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US7469278B2 (en) * 2000-01-21 2008-12-23 Scriptlogic Corporation Validation of portable computer type prior to configuration of a local run-time environment
WO2001074164A1 (en) * 2000-03-31 2001-10-11 The General Hospital Corporation Methods of modulating hair growth
US6730016B1 (en) * 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US20050120113A1 (en) * 2000-06-28 2005-06-02 Accountability International, Inc. System and method for monitoring application utilization
US6719970B1 (en) * 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
US6981252B1 (en) * 2000-07-14 2005-12-27 Symantec Corporation Method and apparatus for automatically uninstalling software on a network
US6898286B2 (en) * 2000-12-19 2005-05-24 International Business Machines Corporation Method and system verifying product licenses using hardware and product identifications
US7192604B2 (en) * 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
US20030211088A1 (en) * 2001-03-12 2003-11-13 Field Loren J. Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
GB2373605B (en) * 2001-03-23 2005-04-27 Ibm A method of metering use of digitally encoded products
US7029838B2 (en) * 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
US20040203146A1 (en) * 2001-04-30 2004-10-14 Dan Gazit Composite scaffolds and methods using same for generating complex tissue grafts
US20030003089A1 (en) * 2001-05-11 2003-01-02 Akins Robert E. Tissue engineered cardiac constructs
US20030131094A1 (en) * 2002-01-10 2003-07-10 International Business Machines Corporation Apparatus and method of limiting application program usage
AU2003226220A1 (en) * 2002-04-03 2003-10-20 Powerquest Corporation Using disassociated images for computer and storage resource management
DE60323561D1 (de) * 2002-05-28 2008-10-30 Toyo Boseki Verfahren zur Kultur, zum Speichern und zur Induzierung von Differenzierung von Zellen und Gerät zur Verwendung in diesem Verfahren, und dazugehöriges Gebrauchsverfahren.
US20040064731A1 (en) * 2002-09-26 2004-04-01 Nguyen Timothy Thien-Kiem Integrated security administrator
KR100483863B1 (ko) * 2002-12-27 2005-04-15 메디칸(주) 고체분말을 이용한 3차원 세포 배양방법
CA2562940A1 (en) * 2004-04-16 2005-12-15 Hydra Biosciences, Inc. Methods of promoting cardiac cell proliferation
US20060115460A1 (en) * 2004-08-30 2006-06-01 Naughton Gail K Compositions and methods comprising WNT proteins to promote repair of damaged tissue
ATE500855T1 (de) * 2004-11-22 2011-03-15 Theregen Inc Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen

Also Published As

Publication number Publication date
JP2008511662A (ja) 2008-04-17
EP1802742A2 (de) 2007-07-04
US20110059059A1 (en) 2011-03-10
AU2005279771A1 (en) 2006-03-09
EP2322600A2 (de) 2011-05-18
AU2005279934A1 (en) 2006-03-09
JP2008511672A (ja) 2008-04-17
WO2006026730A2 (en) 2006-03-09
WO2006026652A3 (en) 2006-08-03
EP1789536A2 (de) 2007-05-30
US20110033434A1 (en) 2011-02-10
EP2322600B1 (de) 2012-03-21
EP2322600A3 (de) 2011-07-27
US20120276062A1 (en) 2012-11-01
US20100034787A1 (en) 2010-02-11
EP1789537A2 (de) 2007-05-30
US20090123435A1 (en) 2009-05-14
US20070237750A1 (en) 2007-10-11
WO2006026730A3 (en) 2006-09-08
WO2006026652A2 (en) 2006-03-09
CA2578951A1 (en) 2006-03-09
AU2005279878A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
ATE550423T1 (de) Dreidimensionale kultivierte gewebe und deren verwendung
DE602004013257D1 (de) Implantate mit lebender Gewebe zur Reparatur von Gewebeschäden oder Gewebedefekten
ATE330000T1 (de) Verwendung von fettgewebe-abgeleiteten stromalen zellen zur differenzierung in chondrozyten und ihre verwendung zur reparatur von knorpelgewebe
EP1406643A4 (de) Physiologische gewebereparatur und funktionale organregeneration durch kultivierung von regenerativen stammzellen in vivo und in situ
WO2005094553A3 (en) Compositions for promoting bone growth and methods thereof
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
DE602004031612D1 (de) Vorrichtung zur abgabe eines implantats durch einen ringförmigen defekt in einer bandscheibe
DE60012628D1 (de) Verwendung eines Aufbewahrungsmittels zur Konservierung von tierischen Zellen, Geweben und Organen
DE60229848D1 (de) - und organtransplantationen und unterdrückt apoptose
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
AU2005221582A8 (en) Tissue repair with multipotent cells
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
WO2003094741A3 (en) Minimally invasive instruments and methods for inserting implants
IL190565A (en) Transplantation facility for endovascular repair and repair of defects in space and tissues
UA99152C2 (ru) Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
ATE543509T1 (de) Material und verfahren zur förderung der reparatur von nervengewebe
EP1494535A4 (de) Zusammensetzungen und minimal invasive verfahren zur behandlung von unvollständiger gewebereparation
DE112007003309A5 (de) Knochenimplantat sowie Set zur Herstellung von Knochenimplantaten
NO20070951L (no) Inhibitorer av angiopoientinlignende-4-protein, kombinasjoner og deres anvendelse.
ATE474528T1 (de) Systeme und techniken zur wiederherstellung und aufrechterhaltung der intervertebralen anatomie
WO2002078439A3 (en) Prevascularized constructs for implantation to provide blood perfusion
DE602004019369D1 (de) Chirurgisches Navigationssystem für mehrteiliges Implantat
WO2005086849A3 (en) Implant scaffold combined with autologous or allogenic tissue
WO2008011524A3 (en) Method of using mitotically inactivated stem cells for damaged tissue repair
WO2007022616A8 (en) Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing